Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on July 16, 2025
Silexion Therapeutics Announces 1-for-15 Reverse Share Split
GlobeNewswire
·
July 16, 2025
Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
GlobeNewswire
·
July 16, 2025
SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufacturing agreement with Sterling …
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
GlobeNewswire
·
July 16, 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global distribution …
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
GlobeNewswire
·
July 16, 2025
GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
TOMI Environmental Solutions Advances New Product, SteraMist Integration System – Standalone (SIS-SA)
GlobeNewswire
·
July 16, 2025
FREDERICK, Md., July 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the successful first installation of its new …
Vystar Launches New Website and Unveils Brand Refresh www.vytex.com
GlobeNewswire
·
July 16, 2025
Boston, MA, July 16, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vytex manufacturer Vystar has today launched a newly-redesigned website www.vytex.com to work alongside the new brand refresh and overall digital strategy. The completely …
Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
GlobeNewswire
·
July 16, 2025
SCOTTSDALE, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") …
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
GlobeNewswire
·
July 16, 2025
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic …
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
·
July 16, 2025
Commack, NY, July 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Full Alliance Group Launches Development of YAHBEE SHOPPING NETWORK — A Web3-Driven, Peer-to-Peer Commerce Revolution
GlobeNewswire
·
July 16, 2025
TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), through its majority-owned subsidiary Qubitera Holdings, proudly announces the launch of the YAHBEE SHOPPING NETWORK — a groundbreaking platform that …
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
GlobeNewswire
·
July 16, 2025
PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has received a letter from the Nasdaq Hearings Panel …
Chiesi and Plug and Play Call for Innovative Solutions to Revolutionize Respiratory Care in the U.S.
GlobeNewswire
·
July 16, 2025
CARY, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- Chiesi, an international biopharmaceutical company (Chiesi Group) and Plug and Play, the world’s largest Open Innovation platform, announced today the launch of Breathing Innovation: The Chiesi Challenge for …
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
GlobeNewswire
·
July 16, 2025
MARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2025 after the market close on …
ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes
GlobeNewswire
·
July 16, 2025
LOS ANGELES, July 16, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, announced today that its 2024 Annual Report has been posted to the company’s official website, www.viaderma.com. Due to the company …
As the Americans with Disabilities Act turns 35, Joni Eareckson Tada’s advocacy continues
GlobeNewswire
·
July 16, 2025
Agoura Hills, CA, July 16, 2025 (GLOBE NEWSWIRE) -- For 35 years, the Americans with Disabilities Act has ensured legal safeguards that protect people with disabilities from discrimination in employment, education, transportation and other aspects of …
Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases
GlobeNewswire
·
July 16, 2025
Amid momentum, the company generates millions in new high-margin revenue for diagnostic network Introduces AI application suites to demonstrate the future of pathology for high-impact use cases Launches 24/7 support to meet the demands of mission-critical, …
Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)
GlobeNewswire
·
July 16, 2025
• Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for …
Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
GlobeNewswire
·
July 16, 2025
Additional complete response (CR) observed in patient with multiple tumors Confirmed overall response rate (ORR) of 50% in patients with combined positive score (CPS) ≥1, including 50% ORR in patients with low CPS (1-19) 12-month overall survival of 88% …
Vantive and Innovative Renal Care Enter into a Long-Term Agreement Focused on Enhanced Use of Technology to Expand Home Dialysis Therapies
GlobeNewswire
·
July 16, 2025
DEERFIELD, Ill. and FRANKLIN, Tenn., July 16, 2025 (GLOBE NEWSWIRE) -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, and Innovative Renal Care (IRC), a comprehensive kidney care provider for patients across the U.S …
Qualigen Granted New Patents Covering 25 Countries
GlobeNewswire
·
July 16, 2025
CARLSBAD, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company” or “Qualigen”) is announcing an update on patents granted in the first six months of 2025. The patent is Titled “Substitued Naphthalene Diimides …